Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 6724-1 is a predicted, non-coding RNA gene classified as a microRNA. Like other microRNAs, it is involved in the post-transcriptional regulation of gene expression, typically by binding to the 3' untranslated regions (UTRs) of messenger RNAs (mRNAs) and repressing their translation or promoting their degradation. The mature miRNA, produced by Dicer processing of a stem-loop precursor, is incorporated into the RNA-induced silencing complex (RISC), guiding gene silencing effects. There is evidence from RNA sequencing studies that a related miRNA-offset RNA (moR-6724-1-5p) is expressed in human B cells and plasma cells and may be differentially regulated in multiple myeloma subgroups, but the specific molecular functions and validated disease links of MIR6724-1 are currently unknown.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 6724-1 (MIR6724-1).